Bio-tech startup BacAlt Biosciences has raised $2 million (about Rs 18 crore) in a pre-seed funding round led by Avaana Capital along with participation from Lubrizol InnoVentures. The company is currently valued at $8 million.
The proceeds will be used to scale its R&D processes, build pilot production facilities, strengthen hiring and develop go-to-market strategies for geographic expansion, BacAlt Biosciences said in a press release.
Co-founded in 2023 by Shruti Kutmutia and Pranav Nair, BacAlt develops bio-based polymers and specialty ingredients…








